{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T23:11:15Z","timestamp":1776294675522,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"S13","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Drug discovery is known for the large amount of money and time it consumes and the high risk it takes. Drug repositioning has, therefore, become a popular approach to save time and cost by finding novel indications for approved drugs. In order to distinguish these novel indications accurately in a great many of latent associations between drugs and diseases, it is necessary to exploit abundant heterogeneous information about drugs and diseases.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>In this article, we propose a meta-path-based computational method called NEDD to predict novel associations between drugs and diseases using heterogeneous information. First, we construct a heterogeneous network as an undirected graph by integrating drug-drug similarity, disease-disease similarity, and known drug-disease associations. NEDD uses meta paths of different lengths to explicitly capture the indirect relationships, or high order proximity, within drugs and diseases, by which the low dimensional representation vectors of drugs and diseases are obtained. NEDD then uses a random forest classifier to predict novel associations between drugs and diseases.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The experiments on a gold standard dataset which contains 1933 validated drug\u2013disease associations show that NEDD produces superior prediction results compared with the state-of-the-art approaches.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12859-020-03682-4","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:03:04Z","timestamp":1600300984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["NEDD: a network embedding based method for predicting drug-disease associations"],"prefix":"10.1186","volume":"21","author":[{"given":"Renyi","family":"Zhou","sequence":"first","affiliation":[]},{"given":"Zhangli","family":"Lu","sequence":"additional","affiliation":[]},{"given":"Huimin","family":"Luo","sequence":"additional","affiliation":[]},{"given":"Ju","family":"Xiang","sequence":"additional","affiliation":[]},{"given":"Min","family":"Zeng","sequence":"additional","affiliation":[]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,9,17]]},"reference":[{"issue":"4","key":"3682_CR1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/bib\/bbr013","volume":"12","author":"JT Dudley","year":"2011","unstructured":"Dudley JT, Deshpande T, Butte AJ. Exploiting drug\u2013disease relationships for computational drug repositioning. Brief Bioinform. 2011;12(4):303\u201311.","journal-title":"Brief Bioinform"},{"issue":"8","key":"3682_CR2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"TT Ashburn","year":"2004","unstructured":"Ashburn TT, Thor KB. Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004;3(8):673.","journal-title":"Nat Rev Drug Discov"},{"key":"3682_CR3","first-page":"9","volume":"12","author":"A Persidis","year":"2011","unstructured":"Persidis A. The benefits of drug repositioning. Drug Discov World. 2011;12:9\u201312.","journal-title":"Drug Discov World"},{"issue":"7","key":"3682_CR4","doi-asserted-by":"crossref","first-page":"654","DOI":"10.7150\/ijbs.9224","volume":"10","author":"JS Shim","year":"2014","unstructured":"Shim JS, Liu JO. Recent advances in drug repositioning for the discovery of new anticancer drugs. Int J Biol Sci. 2014;10(7):654.","journal-title":"Int J Biol Sci"},{"issue":"2","key":"3682_CR5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/ph11020057","volume":"11","author":"J Yella","year":"2018","unstructured":"Yella J, Yaddanapudi S, Wang Y, Jegga A. Changing trends in computational drug repositioning. Pharmaceuticals. 2018;11(2):57.","journal-title":"Pharmaceuticals"},{"issue":"18","key":"3682_CR6","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.2174\/15680266113136660164","volume":"13","author":"B Bolg\u00e1r","year":"2013","unstructured":"Bolg\u00e1r B, Arany A, Temesi G, Balogh B, Antal P, Matyus P. Drug repositioning for treatment of movement disorders: from serendipity to rational discovery strategies. Curr Top Med Chem. 2013;13(18):2337\u201363.","journal-title":"Curr Top Med Chem"},{"key":"3682_CR7","doi-asserted-by":"crossref","first-page":"d741","DOI":"10.1136\/bmj.d741","volume":"342","author":"AF Shaughnessy","year":"2011","unstructured":"Shaughnessy AF. Old drugs, new tricks. BMJ. 2011;342:d741.","journal-title":"BMJ"},{"issue":"11","key":"3682_CR8","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/bioinformatics\/btn138","volume":"24","author":"S Ha","year":"2008","unstructured":"Ha S, Seo YJ, Kwon MS, Chang BH, Han CK, Yoon JH. IDMap: facilitating the detection of potential leads with therapeutic targets. Bioinformatics. 2008;24(11):1413\u20135.","journal-title":"Bioinformatics"},{"issue":"1","key":"3682_CR9","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/msb.2011.26","volume":"7","author":"A Gottlieb","year":"2011","unstructured":"Gottlieb A, Stein GY, Ruppin E, Sharan R. PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol Syst Biol. 2011;7(1):496.","journal-title":"Mol Syst Biol"},{"issue":"1","key":"3682_CR10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/bib\/bbv020","volume":"17","author":"J Li","year":"2015","unstructured":"Li J, Zheng S, Chen B, Butte AJ, Swamidass SJ, Lu Z. A survey of current trends in computational drug repositioning. Brief Bioinform. 2015;17(1):2\u201312.","journal-title":"Brief Bioinform"},{"issue":"1","key":"3682_CR11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1758-2946-5-30","volume":"5","author":"F Napolitano","year":"2013","unstructured":"Napolitano F, Zhao Y, Moreira VM, Tagliaferri R, Kere J, D\u2019Amato M, Greco D. Drug repositioning: a machine-learning approach through data integration. J Cheminform. 2013;5(1):30.","journal-title":"J Cheminform"},{"issue":"7","key":"3682_CR12","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1021\/acs.molpharmaceut.6b00248","volume":"13","author":"A Aliper","year":"2016","unstructured":"Aliper A, Plis S, Artemov A, Ulloa A, Mamoshina P, Zhavoronkov A. Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data. Mol Pharm. 2016;13(7):2524\u201330.","journal-title":"Mol Pharm"},{"key":"3682_CR13","unstructured":"Ramsundar B, Kearnes S, Riley P, Webster D, Konerding D, Pande V. Massively multitask networks for drug discovery. arXiv preprint arXiv. 2015:1502.02072."},{"key":"3682_CR14","first-page":"172","volume":"2014","author":"Q Zhu","year":"2014","unstructured":"Zhu Q, Tao C, Shen F, Chute CG. Exploring the pharmacogenomics knowledge base (PharmGKB) for repositioning breast cancer drugs by leveraging web ontology language (OWL) and cheminformatics approaches. Biocomput. 2014;2014:172\u201382.","journal-title":"Biocomput"},{"issue":"7","key":"3682_CR15","doi-asserted-by":"crossref","first-page":"e1002574","DOI":"10.1371\/journal.pcbi.1002574","volume":"8","author":"B Chen","year":"2012","unstructured":"Chen B, Ding Y, Wild DJ. Assessing drug target association using semantic linked data. PLoS Comput Biol. 2012;8(7):e1002574.","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"3682_CR16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.artmed.2014.11.003","volume":"63","author":"V Mart\u00ednez","year":"2015","unstructured":"Mart\u00ednez V, Navarro C, Cano C, Fajardo W, Blanco A. DrugNet: network-based drug\u2013disease prioritization by integrating heterogeneous data. Artif Intell Med. 2015;63(1):41\u20139.","journal-title":"Artif Intell Med"},{"issue":"1","key":"3682_CR17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41467-017-00680-8","volume":"8","author":"Y Luo","year":"2017","unstructured":"Luo Y, Zhao X, Zhou J, Yang J, Zhang Y, Kuang W, et al. A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information. Nat Commun. 2017;8(1):573.","journal-title":"Nat Commun"},{"issue":"17","key":"3682_CR18","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1093\/bioinformatics\/btw228","volume":"32","author":"H Luo","year":"2016","unstructured":"Luo H, Wang J, Li M, Luo J, Peng X, Wu FX, Pan Y. Drug repositioning based on comprehensive similarity measures and bi-random walk algorithm. Bioinformatics. 2016;32(17):2664\u201371.","journal-title":"Bioinformatics"},{"key":"3682_CR19","doi-asserted-by":"crossref","unstructured":"Yang C, Sun M, Liu Z, Tu C. Fast network embedding enhancement via high order proximity approximation. In: Proceedings of the 26th International Joint Conference on Artificial Intelligence. United States: AAAI Press; 2017:3894\u2013900.","DOI":"10.24963\/ijcai.2017\/544"},{"key":"3682_CR20","doi-asserted-by":"crossref","unstructured":"Fu TY, Lee WC, Lei Z. Hin2vec: explore meta-paths in heterogeneous information networks for representation learning. In: Proceedings of the 2017 ACM on conference on information and knowledge management. United States: Association for Computing Machinery; 2017. 1797\u2013806.","DOI":"10.1145\/3132847.3132953"},{"key":"3682_CR21","first-page":"3111","volume-title":"Advances in neural information processing systems","author":"T Mikolov","year":"2013","unstructured":"Mikolov T, Sutskever I, Chen K, Corrado GS, Dean J. Distributed representations of words and phrases and their compositionality. In: Advances in neural information processing systems; 2013. p. 3111\u20139."},{"key":"3682_CR22","first-page":"2579","volume":"9","author":"LVD Maaten","year":"2008","unstructured":"Maaten LVD, Hinton G. Visualizing data using t-SNE. J Mach Learn Res. 2008;9:2579\u2013605.","journal-title":"J Mach Learn Res"},{"key":"3682_CR23","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, et al. Scikit-learn: machine learning in python. J Mach Learn Res. 2011;12:2825\u201330.","journal-title":"J Mach Learn Res"},{"key":"3682_CR24","first-page":"53","volume":"2013","author":"W Wang","year":"2013","unstructured":"Wang W, Yang S, Li JING. Drug target predictions based on heterogeneous graph inference. Biocomput. 2013;2013:53\u201364.","journal-title":"Biocomput"},{"issue":"5","key":"3682_CR25","doi-asserted-by":"crossref","first-page":"e1002503","DOI":"10.1371\/journal.pcbi.1002503","volume":"8","author":"F Cheng","year":"2012","unstructured":"Cheng F, Liu C, Jiang J, Lu W, Li W, Liu G, et al. Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Comput Biol. 2012;8(5):e1002503.","journal-title":"PLoS Comput Biol"},{"key":"3682_CR26","doi-asserted-by":"crossref","unstructured":"Hussein R, Yang D, Cudr\u00e9-Mauroux P. Are Meta-paths necessary?: revisiting heterogeneous graph Embeddings. In: Proceedings of the 27th ACM international conference on information and knowledge management. United States: Association for Computing Machinery; 2018. p. 437\u201346.","DOI":"10.1145\/3269206.3271777"},{"issue":"suppl_1","key":"3682_CR27","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006;34(suppl_1):D668\u201372.","journal-title":"Nucleic Acids Res"},{"issue":"suppl_1","key":"3682_CR28","first-page":"D514","volume":"33","author":"A Hamosh","year":"2005","unstructured":"Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 2005;33(suppl_1):D514\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"3682_CR29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1021\/ci025584y","volume":"43","author":"C Steinbeck","year":"2003","unstructured":"Steinbeck C, Han Y, Kuhn S, Horlacher O, Luttmann E, Willighagen E. The chemistry development kit (CDK): an open-source Java library for chemo-and bioinformatics. J Chem Inf Comput Sci. 2003;43(2):493\u2013500.","journal-title":"J Chem Inf Comput Sci"},{"issue":"2","key":"3682_CR30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1021\/ci00062a008","volume":"29","author":"D Weininger","year":"1989","unstructured":"Weininger D, Weininger A, Weininger JL. SMILES. 2. Algorithm for generation of unique SMILES notation. J Chem Inf Comput Sci. 1989;29(2):97\u2013101.","journal-title":"J Chem Inf Comput Sci"},{"issue":"5","key":"3682_CR31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/sj.ejhg.5201585","volume":"14","author":"MA Van Driel","year":"2006","unstructured":"Van Driel MA, Bruggeman J, Vriend G, Brunner HG, Leunissen JA. A text-mining analysis of the human phenome. Eur J Hum Genet. 2006;14(5):535.","journal-title":"Eur J Hum Genet"},{"issue":"20","key":"3682_CR32","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1093\/bioinformatics\/btu403","volume":"30","author":"W Wang","year":"2014","unstructured":"Wang W, Yang S, Zhang X, Li J. Drug repositioning by integrating target information through a heterogeneous network model. Bioinformatics. 2014;30(20):2923\u201330.","journal-title":"Bioinformatics"},{"issue":"D1","key":"3682_CR33","doi-asserted-by":"crossref","first-page":"D1075","DOI":"10.1093\/nar\/gkv1075","volume":"44","author":"M Kuhn","year":"2015","unstructured":"Kuhn M, Letunic I, Jensen LJ, Bork P. The SIDER database of drugs and side effects. Nucleic Acids Res. 2015;44(D1):D1075\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"3682_CR34","doi-asserted-by":"crossref","first-page":"D972","DOI":"10.1093\/nar\/gkw838","volume":"45","author":"AP Davis","year":"2016","unstructured":"Davis AP, Grondin CJ, Johnson RJ, Sciaky D, King BL, McMorran R, et al. The comparative toxicogenomics database: update 2017. Nucleic Acids Res. 2016;45(D1):D972\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"3682_CR35","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2146\/ajhp070607","volume":"66","author":"MU Farooq","year":"2009","unstructured":"Farooq MU, Bhatt A, Majid A, Gupta R, Khasnis A, Kassab MY. Levetiracetam for managing neurologic and psychiatric disorders. Am J Health Syst Pharm. 2009;66(6):541\u201361.","journal-title":"Am J Health Syst Pharm"},{"issue":"11","key":"3682_CR36","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1001\/archinte.1988.00380110024005","volume":"148","author":"PA Abraham","year":"1988","unstructured":"Abraham PA, Opsahl JA, Halstenson CE, Keane WF. Efficacy and renal effects of enalapril therapy for hypertensive patients with chronic renal insufficiency. Arch Intern Med. 1988;148(11):2358\u201362.","journal-title":"Arch Intern Med"},{"issue":"6","key":"3682_CR37","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1203\/00006450-197206000-00004","volume":"6","author":"JF Rosen","year":"1972","unstructured":"Rosen JF, Finberg L. Vitamin D-dependent rickets: actions of parathyroid hormone and 25-hydroxycholecalciferol. Pediatr Res. 1972;6(6):552.","journal-title":"Pediatr Res"},{"issue":"5 Suppl","key":"3682_CR38","doi-asserted-by":"crossref","first-page":"87S","DOI":"10.1016\/S8756-3282(99)00072-1","volume":"24","author":"A Grauer","year":"1999","unstructured":"Grauer A, Heichel S, Knaus J, Dosch E, Ziegler R. Ibandronate treatment in Paget's disease of bone. Bone. 1999;24(5 Suppl):87S\u20139S.","journal-title":"Bone"},{"key":"3682_CR39","doi-asserted-by":"crossref","unstructured":"Seifi M, Amdjadi P, Tayebi L. Pharmacological agents for bone remodeling: an experimental approach. In: Biomaterials for oral and dental tissue engineering. United Kingdom: Woodhead Publishing; 2017. p. 503\u201323.","DOI":"10.1016\/B978-0-08-100961-1.00028-1"},{"issue":"3","key":"3682_CR40","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1210\/jc.2011-1319","volume":"97","author":"EA Imel","year":"2012","unstructured":"Imel EA, Econs MJ. Approach to the hypophosphatemic patient. J Clin Endocrinol Metabol. 2012;97(3):696\u2013706.","journal-title":"J Clin Endocrinol Metabol"},{"key":"3682_CR41","doi-asserted-by":"crossref","unstructured":"Qavi AH, Kamal R, Schrier RW. Clinical use of diuretics in heart failure, cirrhosis, and nephrotic syndrome. Int J Nephrol. 2015;2015:975934.","DOI":"10.1155\/2015\/975934"},{"issue":"2","key":"3682_CR42","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/0256-4947.75590","volume":"31","author":"AM Habeb","year":"2011","unstructured":"Habeb AM, George ET, Mathew V, Hattersley AL. Response to oral gliclazide in a pre-pubertal child with hepatic nuclear factor-1 alpha maturity onset diabetes of the young. Ann Saudi Med. 2011;31(2):190\u20133.","journal-title":"Ann Saudi Med"},{"issue":"6","key":"3682_CR43","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10637-006-9035-2","volume":"24","author":"R Suppiah","year":"2006","unstructured":"Suppiah R, Wood L, Elson P, Budd GT. Phase I\/II study of docetaxel, ifosfamide, and doxorubicin in advanced, recurrent, or metastatic soft tissue sarcoma (STS). Investig New Drugs. 2006;24(6):509\u201314.","journal-title":"Investig New Drugs"},{"key":"3682_CR44","first-page":"307","volume-title":"Seminars in dialysis","author":"GO Wolisi","year":"2005","unstructured":"Wolisi, G. O., & Moe, S. M. (2005). Vitamin D in health and disease: the role of vitamin D in vascular calcification in chronic kidney disease. In Seminars in dialysis. Oxford: Blackwell Science Inc.; 18(4):307\u2013314."},{"key":"3682_CR45","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1038\/ki.2008.512","volume":"74","author":"B Lopez","year":"2008","unstructured":"Lopez B, Gonz\u00e1lez A, Hermida N, Laviades C, D\u00edez J. Myocardial fibrosis in chronic kidney disease: potential benefits of torasemide: new strategies to prevent cardiovascular risk in chronic kidney disease. Kidney Int. 2008;74:S19\u201323.","journal-title":"Kidney Int"},{"issue":"1","key":"3682_CR46","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12859-016-1205-4","volume":"17","author":"P Li","year":"2016","unstructured":"Li P, Nie Y, Yu J. Fusing literature and full network data improves disease similarity computation. BMC Bioinform. 2016;17(1):326.","journal-title":"BMC Bioinform"},{"key":"3682_CR47","volume-title":"IEEE\/ACM transactions on computational biology and bioinformatics","author":"R Qin","year":"2019","unstructured":"Qin R, Duan L, Zheng H, Li-Ling J, Song K, Zhang Y. An ontology-independent representation learning for similar disease detection based on multi-layer similarity network. In: IEEE\/ACM transactions on computational biology and bioinformatics; 2019."}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-020-03682-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-020-03682-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-020-03682-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T23:11:50Z","timestamp":1631833910000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-020-03682-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":47,"journal-issue":{"issue":"S13","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["3682"],"URL":"https:\/\/doi.org\/10.1186\/s12859-020-03682-4","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"17 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"387"}}